The nonsteroidal anti-inflammatory drug, nabumetone, differentially inhibits β-catenin signaling in the MIN mouse and azoxymethane-treated rat models of colon carcinogenesis

Hemant K. Roy, William J. Karolski, Ramesh K. Wali, Anne Ratashak, John Hart, Thomas C. Smyrk

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'The nonsteroidal anti-inflammatory drug, nabumetone, differentially inhibits β-catenin signaling in the MIN mouse and azoxymethane-treated rat models of colon carcinogenesis'. Together they form a unique fingerprint.

Medicine & Life Sciences